Evaluation of Diagnostic Performance of Three Commercial Interferon-Gamma Release Assays for <i>Mycobacterium tuberculosis</i>.

In contrast, the TBF-ELISA may be relatively better in ruling-out a diagnosis, and, given that the estimated LR− < 0.1, the contribution to lowering the posterior probability that the patient has the disease may be significant. 3.3.

also in 13,097 other papers

These results indicate that the QFT-Plus may be relatively better when ruling-in a diagnosis, although its contribution to diagnosis may not be significant given that the estimated LR+ < 10.

also in 2,774 other papers